Dr. Anne Rodallec
First Name / Last Name : Anne Rodallec
Title or function : PharmD, PhD, Assistant Professor in Pharmacokinetics
Affiliation (Lab, university, company) : COMPO/SMARTc, CRCM, Inserm 1068, CNRS UMR 7258, AMU U105, IPC, Inria
First Name / Last Name : Anne Rodallec
Title or function : PharmD, PhD, Assistant Professor in Pharmacokinetics
Affiliation (Lab, university, company) : COMPO/SMARTc, CRCM, Inserm 1068, CNRS UMR 7258, AMU U105, IPC, Inria
I am an Assistant professor at Aix Marseille University, in the Department of Pharmacokinetics, of the Faculty of Pharmacy of Marseille where I mostly teach pharmacokinetics and offer hands on using pharmacometric softwares and languages to answer a pharmaceutical issue.
I am also a part of the Marseille Cancer Research Center (CRCM) where I have two main research axis in preclinical studies (i) development of nanoparticles in oncology to optimize current cancer treatments (ii) development of mathematical models (i.e., PK/PD and PBPK) to determine optimal administration schemes.
Rodallec A, Franco C, Robert S, Sicard G, Giacometti S, Lacarelle B, Bouquet F, Savine A, Lacroix R, Dignat-George F, Ciccolini J, Poncelet P, Fanciullino R. Prototyping trastuzumab docetaxel immunoliposomes with a new FCM-based method to quantify optimal antibody density on nanoparticles. Scientific Reports 2020 Mar 5;10(1):4147. .
Rodallec A, Fanciullino R, Benzekry S, Ciccolini J, Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology. Anticancer Research 39: 2019. .
Rodallec A, Sicard G, Giacometti S, Carre M, Pourroy B, Bouquet F, Savina A, Lacarelle B, Ciccolini J, Fanciullino R. From 3D spheroids to mice: Efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer. Int J Nanomedicine. 2018 Oct 23;13:6677-6688. .